COMP <GO>
KMTS vs INSP // DIVIDEND YIELD & FCF PAYOUT SAFETY
Kestra Medical Technologies Ltd. (NASDAQ) VS. Inspire Medical Systems Inc. (NYSE) • 15-METRIC TALLY: KMTS 2
— INSP 8
■ METRIC PARITY
LAST: $30.61 (+2.48%) • MKT CAP: $1.82B
dividend-safety
0.00%
LAST: $71.18 (+0.30%) • MKT CAP: $2.06B
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KMTS VS. INSP)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | KMTS | INSP | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 51.40% | 85.40% | -34.00 | INSP | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 6.00% | -41.00 | INSP | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 23.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -6.40% | 3.81% | -10.21 | INSP | /fcf-yield <GO> |
| Operating Margin | -60.00% | 5.60% | -65.60 | INSP | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 15.90% | -75.90 | INSP | /net-margins <GO> |
| Revenue Growth (YoY) | 59.00% | 13.60% | +45.40 | KMTS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 9.65 | 11.40 | -1.75 | INSP | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | INSP | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 60.8 | 53.5 | +7.30 | KMTS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 11.9x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.82B | $2.06B | -$234.7M | INSP | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | KMTS REV | INSP REV | KMTS GROSS % | INSP GROSS % | KMTS FCF | INSP FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $95.1M | $912.0M | 51.4% | 85.4% | -$116.6M | $78.5M |
| FY 2024 | $59.8M | $802.8M | 40.5% | 84.7% | -$100.5M | $91.1M |
| FY 2023 | $27.8M | $624.8M | — | — | -$72.2M | $24.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KMTS // BETA —
INSP // BETA —